Test of Aquatic Mobility of SMA Infants
BAINSMA
Analysis of Mobility in the Bath for Infants Affected With Spinal Muscular Atrophy
2 other identifiers
interventional
15
1 country
1
Brief Summary
Spinal muscular atrophy (SMA) is a genetic neurodegenerative disease impacting spinal cord motor neurons, leading to motor and respiratory issues and, ultimately, death. With emerging therapies, a need arises to enhance motor function assessment in severely hypotonic infants (SMA type 1) as traditional scales on examination tables lack completeness due to gravity's influence. The study team has developed a "bath test" to observe infants' motor skills in water, eliminating gravity's effects. This test aims to detect subtle movements using inertial sensors, potentially revealing more active motor neurons in aquatic conditions. It aids in identifying infants with motor improvement potential, even if they show limited mobility outside water, and tracks disease progression and therapy responses. Presently, pediatric neurologists in France use parent-provided bathing videos for evaluations, but these lack standardization and precision. The study aims to establish a standardized evaluation protocol with quantifiable data. The study's key objective is to evaluate severely hypotonic SMA infants using inertial sensors, including accelerometers, gyrometers, and magnetometers. The study will conduct "dry" and "water" assessments using a specially designed bathtub. This method's goal is to quantify water-based movements accurately. Simultaneously, the study seeks to establish semi-quantitative evaluation criteria to create a clinical assessment scale for infant motor function in bathtubs. This scale will aid doctors in therapeutic decisions. The study will not influence the treatment or therapeutic decisions made for the children being tested. Collected data from "dry" and "water" conditions will be statistically analyzed and compared to reference motor assessment scales (e.g., CHOP INTEND and HINE) and electromyography (CMAP-EMG) results, commonly used in diagnosis and monitoring. Blurred video recordings will assist in protocol monitoring and sensor data analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 30, 2023
CompletedFirst Posted
Study publicly available on registry
November 30, 2023
CompletedStudy Start
First participant enrolled
June 26, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
November 21, 2025
September 1, 2025
11 months
October 30, 2023
November 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Delta of 95th percentile of free acceleration norm (in m/s²)
Difference of free acceleration norm (in m/s²) for each measurement point respectively (elbows; wrists; knees; ankles), between "dry" and "water" condition.
through study completion, an average of 15 months
Study Arms (1)
Mobility Assessment
EXPERIMENTALThis study involves a single arm, without a comparator group. The comparison will be made between the data for movements in conditions outside the water and inside the water.
Interventions
Record the movements of the baby's extremities using inertial sensors while the baby moves outside of the water.
Record the movements of the baby's extremities using inertial sensors while the baby moves inside the water.
Eligibility Criteria
You may qualify if:
- Infants with muscle weakness (commonly referred to as floppy babies):
- Confirmed diagnosis of SMA through gene mutation or deletion (SMN1 gene).
- Receiving standard care.
- Patients enrolled in a social security scheme.
- Informed consent signed by both parents of the child and the investigator.
You may not qualify if:
- Patients presenting with lesions in the spinal cord or conditions affecting the cardiorespiratory system.
- Patients covered under the French Aid in Health for Foreign People program (AME).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Infantile neuromuscular unity - Department of paediatric neurological care and intentive care unity, Raymond Poincaré Hospital - APHP
Garches, 92380, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susana Quijano-Roy, MD, PhD
Paediatric neurological and intentive care unity, Raymond Poincaré Hospital - APHP
- STUDY DIRECTOR
Nour Maalouf, Psychomotor Therapist DE
Paediatric neurological and intentive care unity, Raymond Poincaré Hospital - APHP
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 30, 2023
First Posted
November 30, 2023
Study Start
June 26, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
November 21, 2025
Record last verified: 2025-09